Mircera Unia Europejska - bułgarski - EMA (European Medicines Agency)

mircera

roche registration gmbh - Метокси полиетилен гликол-эпоэтин бета - anemia; kidney failure, chronic - Антианемични препарати - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5. treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.

TSEFALEN 1000 mg FILM-COATED TABLETS FOR DOGS Bułgaria - bułgarski - БАБХ (Българска агенция по безопасност на храните)

tsefalen 1000 mg film-coated tablets for dogs

nexmune italy s.r.l. - Цефалексина - филмирани таблетки - 1000 mg/таблетка - кучета

RILEXINE 200 T Bułgaria - bułgarski - БАБХ (Българска агенция по безопасност на храните)

rilexine 200 t

virbac - Цефалексина (като монохидрат) - интрамамарна суспензия - 200 mg/спринцовка - крави

RILEXINE 15 inj. 15 g/100 ml Bułgaria - bułgarski - БАБХ (Българска агенция по безопасност на храните)

rilexine 15 inj. 15 g/100 ml

virbac - Цефалексина (като монохидрат) - инжекционна суспензия - 15 g/100 ml - говеда

MASTILEX Bułgaria - bułgarski - БАБХ (Българска агенция по безопасност на храните)

mastilex

invesa international, s.a. - Цефалексин (монохидрат); Гентамицин (сулфат) - интрамамарна суспензия - 350 mg/10 ml, 35 mg/10 ml - крави

Zinforo Unia Europejska - bułgarski - EMA (European Medicines Agency)

zinforo

pfizer ireland pharmaceuticals - fosamil цефтаролин - community-acquired infections; skin diseases, infectious; pneumonia - Антибактериални средства за подаване на заявления, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.